Ekf Diagnostics
Ekf Diagnostics, officially known as EKF Diagnostics Holdings plc, is a prominent player in the global diagnostics industry, headquartered in Great Britain. Founded in 2000, the company has established itself as a leader in point-of-care testing and laboratory diagnostics, with a strong operational presence across Europe, North America, and Asia. Specialising in innovative products such as blood glucose monitoring systems, haemoglobin analysers, and molecular diagnostics, EKF Diagnostics is recognised for its commitment to quality and accuracy. The company’s unique approach combines advanced technology with user-friendly designs, catering to the needs of healthcare professionals and patients alike. With a solid market position, EKF Diagnostics has achieved significant milestones, including strategic partnerships and a growing portfolio of patented technologies, solidifying its reputation as a trusted provider in the healthcare sector.
DitchCarbon Score
How does Ekf Diagnostics's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Ekf Diagnostics's score of 20 is lower than 51% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Ekf Diagnostics's reported carbon emissions
In 2023, EKF Diagnostics, headquartered in Great Britain, reported total emissions of approximately 473,000 kg CO2e, with Scope 1 emissions from mobile combustion accounting for about 79,000 kg CO2e. This marks a significant increase from 2022, when total emissions were around 338,000 kg CO2e, with Scope 1 emissions at approximately 21,000 kg CO2e. Despite the increase in emissions, EKF Diagnostics has not set specific reduction targets or initiatives, as indicated by the absence of documented reduction targets or commitments to frameworks such as the Science Based Targets initiative (SBTi). The company does not disclose Scope 2 or Scope 3 emissions data, which limits the understanding of its overall carbon footprint. The emissions data is not cascaded from a parent company, and all figures are reported directly by EKF Diagnostics Holdings plc. The company continues to operate within the diagnostics industry, which is increasingly focusing on sustainability and carbon reduction, yet it currently lacks formal commitments to climate pledges or reduction initiatives.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | |
|---|---|
| Scope 1 | 21,351,000 |
| Scope 2 | - |
| Scope 3 | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Ekf Diagnostics is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
